ADAR1 Capital Management »

Cytomx Therapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 904k 1.18
2024-06-30 $698k 572k 1.22
2024-03-31 $338k 155k 2.18

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Cytomx Therapeutics

Tang Capital Management
BVF
Vanguard Group
Henderson Group
Acadian Asset Management
Prosight Management
Adage Capital Partners GP
Millennium Management
Jacobs Levy Equity Management
Laurion Capital Management
Schonfeld Strategic Advisors
BlackRock
Renaissance Technologies
Congress Park Capital
Altium Capital Management

View all funds holding Cytomx Therapeutics